Abstract
The purpose of this document is to report the Sarcoma National Managed Clinical Network (NMCN)
activities in respect of:
Performance against agreed work plan objectives;
Outcomes achieved; and
Challenges encountered and actions taken to remedy defined issues.
This report covers the activity of the NMCN between April 2021 and March 2022. It also reports on the findings and resultant actions required from the 2020/21 clinical audit report, as well as looking forward from April 2022 to March 2023.
activities in respect of:
Performance against agreed work plan objectives;
Outcomes achieved; and
Challenges encountered and actions taken to remedy defined issues.
This report covers the activity of the NMCN between April 2021 and March 2022. It also reports on the findings and resultant actions required from the 2020/21 clinical audit report, as well as looking forward from April 2022 to March 2023.
| Original language | English |
|---|---|
| Place of Publication | [s.l.] |
| Number of pages | 15 |
| Publication status | Published - 31 Mar 2022 |
Keywords
- quality performance indicators
- sarcoma
- audit